BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8778034)

  • 1. Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.
    Sheikh NA; Caro HN; Taverne J; Playfair JH; Rademacher TW
    Immunology; 1996 Mar; 87(3):461-6. PubMed ID: 8778034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulators of tumour necrosis factor production released by damaged erythrocytes.
    Bate CA; Kwiatkowski DP
    Immunology; 1994 Oct; 83(2):256-61. PubMed ID: 7835944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.
    Bate CA; Taverne J; Román E; Moreno C; Playfair JH
    Immunology; 1992 Jan; 75(1):129-35. PubMed ID: 1537589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive destruction of malaria-parasitized red blood cells despite spleen closure.
    Krücken J; Mehnert LI; Dkhil MA; El-Khadragy M; Benten WP; Mossmann H; Wunderlich F
    Infect Immun; 2005 Oct; 73(10):6390-8. PubMed ID: 16177310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.
    Clark IA; Hunt NH; Butcher GA; Cowden WB
    J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
    Taverne J; Tavernier J; Fiers W; Playfair JH
    Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG-coated erythrocytes augment LPS-stimulated TNF-alpha secretion, TNF-alpha mRNA levels, and TNF-alpha mRNA stability in macrophages.
    Richard CA; Wilcox BD; Loegering DJ
    Biochem Biophys Res Commun; 2000 Apr; 271(1):70-4. PubMed ID: 10777683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional effects of extracellular pH on tumour necrosis factor-alpha production in RAW 246.7 and J774 A.1 cells.
    Heming TA; Tuazon DM; Davé SK; Chopra AK; Peterson JW; Bidani A
    Clin Sci (Lond); 2001 Mar; 100(3):259-66. PubMed ID: 11222111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response.
    Comstock KL; Krown KA; Page MT; Martin D; Ho P; Pedraza M; Castro EN; Nakajima N; Glembotski CC; Quintana PJ; Sabbadini RA
    J Mol Cell Cardiol; 1998 Dec; 30(12):2761-75. PubMed ID: 9990546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.
    Hamilton JA; Whitty GA; Kola I; Hertzog PJ
    J Immunol; 1996 Apr; 156(7):2553-7. PubMed ID: 8786318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected problems of malaria blood stage immunity.
    Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
    Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of TNF in vitro as a model for the identification of toxic malaria antigens.
    Taverne J; Bate CA; Playfair JH
    Lymphokine Res; 1989; 8(3):317-22. PubMed ID: 2674557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative hyperoxia augments lipopolysaccharide-stimulated cytokine secretion by murine macrophages.
    Danielson DS; Heagy W; Nieman KM; West MA
    Surgery; 2003 May; 133(5):538-46. PubMed ID: 12773982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plasmodium chabaudi chabaudi AS infection.
    Clark K; Kulk N; Amante F; Haque A; Engwerda C
    Parasite Immunol; 2007 Mar; 29(3):153-8. PubMed ID: 17266742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
    Taverne J; Matthews N; Depledge P; Playfair JH
    Clin Exp Immunol; 1984 Aug; 57(2):293-300. PubMed ID: 6467675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
    Okamoto H; Kimura M; Watanabe N; Ogihara M
    Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha.
    Hilmy KM
    Arch Pharm (Weinheim); 2004 Jan; 337(1):15-9. PubMed ID: 14760623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of RNA interference on expression of tumor necrosis factor-alpha in lipopolysaccharide-activated mouse macrophages].
    Tan B; Li YY; Nie YQ; DU YL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2140-3. PubMed ID: 17988537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.